DIA: Driving Insights to Action

Who Determines the Price of Medicines – and How?

Who determines how much society and/or patients should pay for a medicine? And how are those determinations made? Dr. Alberto Grignolo, Deputy Editor for DIA’s Global Forum, discusses these and related questions with Professor Sarah Garner, Associate Director, Science Policy & Research, for the UK's National Institute for Health and Care Excellence (NICE), and a pharmacist with special expertise in the interface between Health Technology Assessment (HTA) and regulation. Professor Garner will participate in a panel discussion on Value-Based Health Care Decision Making: The Quest for Smarter Spending at our DIA 2016 Annual Meeting in Philadelphia.

“An Urgent Imperative Now to Learn Quickly”: DIA 2016 Co-Chair Dr. Gigi Hirsch

Dr. Gigi Hirsch is the Executive Director of the MIT Center for Biomedical Innovation (CBI). As part of her mission to innovate the drug development process, Dr. Hirsch will serve as Co-Chair of the DIA 2016 Annual Meeting in Philadelphia, where she will also participate in a panel discussion on Europe and the US: Making Outcomes-Based Health Care Possible. “DIA provides an incredibly powerful platform for engaging globally around some of the most important innovations that are happening in real time and need to continue to evolve,” she explains in this exclusive interview with DIA Global Forum Deputy Editor Dr. Alberto Grignolo.

Industry-Patient Relations: Culture Change or Culture Shock?

Effective engagement between patients and industry, regulatory agencies, and other stakeholders, requires organizational cultures that place high priority and focus on patients. As Associate Director, Diversity & Patient Engagement, for Bristol-Myers Squibb Company, Mary Stober Murray builds relationships with advocacy organizations, patient communities, and provider communities, to keep them informed, educated, and prepared to support clinical development of BMS compounds. Mary will contribute her voice to the panel discussion on Changing Cultures to Advance Patient Engagement during the DIA2016 Annual Meeting in Philadelphia, and shares her experiences in this exclusive interview with DIA Global Forum Deputy Editor Dr. Alberto Grignolo.

Every Journey Begins with a First Step: DIA Patient Engagement

Dr. Yves Juillet, Secretary General of the Academy of Medicine Foundation in France, is one of the persons most responsible for DIA’s first formal steps into patient engagement. For more than two decades, Dr. Juillet has been deeply involved with DIA, serving on the Advisory Council of Europe, the Board of Directors, and as DIA President. In 2013, he was named Honorary President of the French Academy of Pharmacy and was also named a DIA Fellow, the organization’s highest honor. In this exclusive Global Forum interview, Dr. Juillet shares what inspired these first steps and reflects on DIA’s subsequent journey into patient engagement.